PMC:7283670 / 72299-72577 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T260","span":{"begin":39,"end":43},"obj":"Body_part"}],"attributes":[{"id":"A260","pred":"fma_id","subj":"T260","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":" nosocomial infection (Day 28), CD4+ T cell count by flow cytometry in two groups (baseline, Day, 3, 6, 10, 14, 21, 28) NCT04288102/Recruiting, May5‐Dec31 2020–2021\nThe clinical study of carrimycin on treatment patients with COVID‐19 Drug: carrimycin, drug: lopinavir/ritonavi"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T401","span":{"begin":1,"end":21},"obj":"Disease"},{"id":"T402","span":{"begin":12,"end":21},"obj":"Disease"},{"id":"T403","span":{"begin":226,"end":234},"obj":"Disease"}],"attributes":[{"id":"A401","pred":"mondo_id","subj":"T401","obj":"http://purl.obolibrary.org/obo/MONDO_0043544"},{"id":"A402","pred":"mondo_id","subj":"T402","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A403","pred":"mondo_id","subj":"T403","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":" nosocomial infection (Day 28), CD4+ T cell count by flow cytometry in two groups (baseline, Day, 3, 6, 10, 14, 21, 28) NCT04288102/Recruiting, May5‐Dec31 2020–2021\nThe clinical study of carrimycin on treatment patients with COVID‐19 Drug: carrimycin, drug: lopinavir/ritonavi"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T632","span":{"begin":32,"end":35},"obj":"http://purl.obolibrary.org/obo/PR_000001004"},{"id":"T633","span":{"begin":37,"end":43},"obj":"http://purl.obolibrary.org/obo/CL_0000084"},{"id":"T634","span":{"begin":98,"end":102},"obj":"http://purl.obolibrary.org/obo/CLO_0001313"}],"text":" nosocomial infection (Day 28), CD4+ T cell count by flow cytometry in two groups (baseline, Day, 3, 6, 10, 14, 21, 28) NCT04288102/Recruiting, May5‐Dec31 2020–2021\nThe clinical study of carrimycin on treatment patients with COVID‐19 Drug: carrimycin, drug: lopinavir/ritonavi"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T258","span":{"begin":254,"end":258},"obj":"Chemical"},{"id":"T260","span":{"begin":260,"end":269},"obj":"Chemical"}],"attributes":[{"id":"A258","pred":"chebi_id","subj":"T258","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A260","pred":"chebi_id","subj":"T260","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"}],"text":" nosocomial infection (Day 28), CD4+ T cell count by flow cytometry in two groups (baseline, Day, 3, 6, 10, 14, 21, 28) NCT04288102/Recruiting, May5‐Dec31 2020–2021\nThe clinical study of carrimycin on treatment patients with COVID‐19 Drug: carrimycin, drug: lopinavir/ritonavi"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1853","span":{"begin":32,"end":35},"obj":"Gene"},{"id":"1920","span":{"begin":212,"end":220},"obj":"Species"}],"attributes":[{"id":"A1853","pred":"tao:has_database_id","subj":"1853","obj":"Gene:920"},{"id":"A1920","pred":"tao:has_database_id","subj":"1920","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" nosocomial infection (Day 28), CD4+ T cell count by flow cytometry in two groups (baseline, Day, 3, 6, 10, 14, 21, 28) NCT04288102/Recruiting, May5‐Dec31 2020–2021\nThe clinical study of carrimycin on treatment patients with COVID‐19 Drug: carrimycin, drug: lopinavir/ritonavi"}